Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells.
about
Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancerApoptomiRs of Breast Cancer: Basics to ClinicsModeling of miRNA and drug action in the EGFR signaling pathwayFunctionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitroUltrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAsRole of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer.Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancerPleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progressionUp-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer.Regulation of cancer metastasis by microRNAs.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.miRNA - Therapeutic tool in breast cancer? Where are we now?MicroRNA-mediated drug resistance in breast cancer.Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.Human anti-nucleolin recombinant immunoagent for cancer therapy.Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer.MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphomaHuman cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel.A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy.Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy.Emerging biomarkers in breast cancer care.Targeting miR-21 in glioma: a small RNA with big potential.miRNAs in breast cancer: ready for real time?MicroRNA control of epithelial-mesenchymal transition and metastasis.MicroRNAs in cancer diagnosis and therapy: from bench to bedside.MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.Delivery of therapeutic nucleic acids via transferrin and transferrin receptors: lipoplexes and other carriers.Epithelial-mesenchymal transition transcription factors and miRNAs: "Plastic surgeons" of breast cancerTargeting the microRNA-regulating DNA damage/repair pathways in cancer.microRNA therapies in cancer.Therapeutic Targeting of microRNAs in Cancer: Future Perspectives.MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4.MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-β1/miR-21/PDCD4 pathway.miRNA-34a is associated with docetaxel resistance in human breast cancer cells.LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21.
P2860
Q28066481-D8B67D93-1F90-419A-9E54-B206EBB594CBQ28072414-7794F9D5-C458-4925-B797-ABFA9E1BDF1CQ28478852-E9E58720-86F4-495F-947F-C9D62DEBECCFQ28488394-979DE673-0A6E-482F-B4C3-F8841097FD98Q30367369-655B5C9D-74EC-44AC-9878-EA00242D4C94Q33559304-2467D3FF-5812-41BA-B205-5252DE27DF92Q33585105-470576B5-3CFB-4FA0-88F2-B780B12FF8E0Q33850064-C56996A4-3BAC-408F-A9B3-4BD3396B83D5Q34048535-47EE60E9-19C2-4F7C-A790-3CFAD0C44875Q34310243-EF9AFAF8-8A5E-4C94-87F7-911796CB3B2CQ34779925-9181907C-6D2D-45C6-AE93-201CF6617775Q34998307-12C72308-DDBD-4D78-A0E9-A6EEF04BE9F9Q35052860-CAFCC336-B1CF-4449-9755-3557CA6ACE6CQ35094742-0DA0F9C7-03D5-4EAA-A03C-E2E4A4D9D7A1Q35113386-BD0B4B3D-A345-44D3-8E43-7A29E169E6F7Q35165126-0B008497-1FED-4DBF-944C-3B76F6B60D36Q35405268-207D27C8-254C-4656-B513-F686F60B0083Q35580945-3FB566E3-7702-4F96-9D9F-11199CD2A01AQ35690196-46041B88-8677-4819-911B-418CA51717C4Q35995713-A96F723D-28C6-49C3-BF7B-B8D97DEED2D1Q37623563-24B36804-FE6B-4C6F-9405-B2613CEC641CQ37694030-079A1559-2FD5-4C68-AE86-5A5F71649AA1Q37699360-9A1CDFDC-D813-4E35-A44A-B4330F22ED23Q37728744-C893828F-E7EE-4238-ADBC-4F8EE5629762Q37779305-E20EB736-C73E-494A-BAA2-C4A7F3AD6EE7Q37799840-C1466E96-3853-42A8-9E80-1C1AE6A7360EQ38003705-06C98D06-08BA-41C4-896A-E331521401DAQ38017596-5B891057-0A5D-4022-AEBA-27C7B9184D08Q38057979-3759C64B-5E16-4EA2-BD00-185EF42A71F5Q38122420-5F1136A0-77C4-4F2D-B1D5-66EB63E17A1FQ38139539-7B9EC08D-8BE7-4B45-B5E9-AD5F4EC238EEQ38239141-4079B082-1ECB-4268-A14B-E07E475DE979Q38246220-64478141-7875-4327-B611-8B3A973A59F8Q38521725-364BDE32-27B5-43F3-8C7B-137CFA226CF9Q38598965-EB09F678-2A58-4310-A68D-89BB10F7605EQ38795162-9E5CC033-BDDD-4E36-9E1F-750FA3E05D5EQ38895915-94EFFE7C-0FD6-4955-A641-56AA07ED2100Q39392869-7D972416-AAF9-48A2-B77C-B509209A1336Q39576802-362C0D4A-D438-491A-8D7A-119D75DB1298Q41498465-15A06DC5-6370-4AB6-B46D-A4DBA78A0145
P2860
Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Downregulation of miR-21 enhan ...... xol in breast carcinoma cells.
@en
Downregulation of miR-21 enhan ...... xol in breast carcinoma cells.
@nl
type
label
Downregulation of miR-21 enhan ...... xol in breast carcinoma cells.
@en
Downregulation of miR-21 enhan ...... xol in breast carcinoma cells.
@nl
prefLabel
Downregulation of miR-21 enhan ...... xol in breast carcinoma cells.
@en
Downregulation of miR-21 enhan ...... xol in breast carcinoma cells.
@nl
P2093
P2860
P1476
Downregulation of miR-21 enhan ...... xol in breast carcinoma cells.
@en
P2093
Chun-sheng Kang
Guang-xiu Wang
Xu-bo Yuan
Zhifan Jia
P2860
P356
10.1177/153303461000900109
P577
2010-02-01T00:00:00Z